Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
Phase 1
Completed
- Conditions
- Moderate to Severe Glabellar Lines
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT03970876
- Locations
- 🇰🇷
Nowon Eulji Medical Center, Eulji University, Seoul, Korea, Republic of
Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults
Phase 1
Completed
- Conditions
- Typhoid Fever
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 75
- Registration Number
- NCT03956524
- Locations
- 🇵🇭
De La Salle Health Sciences Institute, Dasmariñas, Cavite, Philippines
To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children
Phase 3
Completed
- Conditions
- Prevention Harmful Effects
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 3632
- Registration Number
- NCT02164110
- Locations
- 🇵🇭
Antonio D. Ligsay, MD, Quezon City, Philippines
To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men
Phase 1
Completed
- Conditions
- Prevention Harmful Effects
- First Posted Date
- 2012-10-16
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT01707537
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungnam, Korea, Republic of